Interferon alfa-2A and ribavirin therapy for hepatitis C recurrence after liver transplantation

被引：8
|
作者：
Wietzke, P
Braun, F
Ringe, B
Ramadori, G
机构：
[1] Univ Gottingen, Abt Gastroenterol & Endokrinol, D-37075 Gottingen, Germany
[2] Univ Gottingen, Klin Transplantat Chirurg, D-37075 Gottingen, Germany
来源：
TRANSPLANTATION PROCEEDINGS | 2000年 / 32卷 / 07期
关键词：
D O I：
10.1016/S0041-1345(00)01782-6
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：2539 / 2542
页数：4
相关论文
共 50 条
  • [1] Pegylated interferon ALFA-2A and ribavirin for recurrent hepatitis C after liver transplantation
    Mukherjee, S
    Rogge, DV
    Weaver, L
    Schafer, DF
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S101 - S101
  • [2] Pegylated interferon alfa-2a and ribavirin for recurrent hepatitis C after liver transplantation
    Mukherjee, S
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (10) : 4403 - 4405
  • [3] HCV RECURRENCE AFTER LIVER TRANSPLANTATION: ROLE OF THERAPY WITH PEGINTERFERON ALFA-2A/RIBAVIRIN IN MAINTENANCE
    Borro, P.
    Sumberaz, A.
    Ansaldi, F.
    Barciocco, D.
    Gentile, R.
    Ancarani, O. A.
    Testino, G.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S246 - S246
  • [4] Aggravated Penile Psoriasis after Treatment of C Hepatitis with Interferon Alfa-2a and Ribavirin Therapy
    Mebazaa, A.
    Moula, H.
    Chouaieb, S.
    El Euch, D.
    Aidli, S.
    Rouhou, R. Cheikh
    Zaraa, I.
    Mokni, M.
    Ben Mami, N.
    Ben Osman, A.
    Daghfous, R.
    DRUG SAFETY, 2009, 32 (10) : 914 - 915
  • [5] A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation
    Gane, EJ
    Lo, SK
    Riordan, SM
    Portmann, BC
    Lau, JYN
    Naoumov, NV
    Williams, R
    HEPATOLOGY, 1998, 27 (05) : 1403 - 1407
  • [6] Treatment of Genotype 4 Hepatitis C Recurring After Liver Transplantation Using a Combination of Pegylated Interferon Alfa-2a and Ribavirin
    Waleed Al-hamoudi
    Hazem Mohamed
    Faisal Abaalkhail
    Yaser Kamel
    Nasser Al-Masri
    Naglaa Allam
    Saleh Alqahtani
    Mohammed Al-Sofayan
    Hatem Khalaf
    Mohammed Al-Sebayel
    Ahmed Al-jedai
    Ayman Abdo
    Digestive Diseases and Sciences, 2011, 56 : 1848 - 1852
  • [7] Treatment of Genotype 4 Hepatitis C Recurring After Liver Transplantation Using a Combination of Pegylated Interferon Alfa-2a and Ribavirin
    Al-Hamoudi, Waleed
    Mohamed, Hazem
    Abaalkhail, Faisal
    Kamel, Yaser
    Al-Masri, Nasser
    Allam, Naglaa
    Alqahtani, Saleh
    Al-Sofayan, Mohammed
    Khalaf, Hatem
    Al-Sebayel, Mohammed
    Al-Jedai, Ahmed
    Abdo, Ayman
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (06) : 1848 - 1852
  • [8] Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation
    Bizollon, T
    Palazzo, U
    Ducerf, C
    Chevallier, M
    Elliott, M
    Baulieux, J
    Pouyet, M
    Trepo, C
    HEPATOLOGY, 1997, 26 (02) : 500 - 504
  • [9] Prediction of treatment response to 72 weeks of pegylated interferon alfa-2a plus ribavirin for chronic hepatitis C after liver transplantation
    Bergk, A.
    Neumann, U. P.
    Van Boemmel, F.
    Wiedenmann, B.
    Berg, T.
    Neuhaus, R.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S218 - S219
  • [10] Therapy of hepatitis C: Interferon alfa-2a trials
    Lee, WM
    HEPATOLOGY, 1997, 26 (03) : S89 - S95
12345